InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Saturday, 11/07/2015 10:17:44 AM

Saturday, November 07, 2015 10:17:44 AM

Post# of 426760
Amarin could do a deal with any of the numerous drug companies that have drugs to treat peripheral vascular disease. All these patients take drugs to prevent clots in lower extremities...none of these drugs reduce plaque volume.

These are the deals Amarin can do now to raise cash, management needs to expand deal possibilities beyond cardiovascular treatments and CHERRY gives them the ability to do this.

BB

Mr. McGee, don't make me angry. You wouldn't like me when I'm angry---David Banner

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News